Gsα availability to cholera toxin-catalysed ADP-ribosylation is decreased in membranes of retinoic acid-treated leukemic cell lines HL-60 and THP-1: A posttranslational effect
- 6 November 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (11), 2141-2146
- https://doi.org/10.1016/0006-2952(91)90349-a
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Identification of a second human retinoic acid receptorNature, 1988
- A human retinoic acid receptor which belongs to the family of nuclear receptorsNature, 1987
- G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALSAnnual Review of Biochemistry, 1987
- G Proteins: A Family of Signal TransducersAnnual Review of Cell Biology, 1986
- ADP-RIBOSYLATIONAnnual Review of Biochemistry, 1985
- Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells.Journal of Clinical Investigation, 1982
- Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)International Journal of Cancer, 1980
- Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemiaBlood, 1979